ARDX
Biotechnology · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Ardelyx, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARDX alertsSusan Hohenleitner is recorded as CFO at Ardelyx, Inc. (ARDX). The newest filing on record that lists Susan Hohenleitner as CFO at Ardelyx, Inc. (ARDX) is dated April 29, 2026. The proxy statement of Ardelyx, Inc. reports total compensation of $3,437,372 for Susan Hohenleitner in fiscal 2025, including a base salary of $120,929. Susan Hohenleitner has spoken on 2 earnings calls across 1 company, most recently for Ardelyx, Inc. on August 6, 2026. Ardelyx, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ardelyx, Inc. includes Michael Raab (CEO and Board Member), Keith Santorelli (CFO), Joseph Reilly (Chief Accounting Officer) and 7 others.
“Our second quarter 2026 financial results reflect the ongoing transformation of our DELICS into a financially strong organization that allows us to leverage our revenue base to fund both our current commercial operations and our advancing pipeline.”
“Four months ago, I joined Ardelix as it was clear to me that I had a unique and incredible opportunity to become part of building a great company, helping patients and creating real value for shareholders.”
Start not stated–present
Last confirmed April 29, 2026
ARDX
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ardelyx, Inc. (ARDX) | Chief Financial Officer | $120,929 | $3,437,372 |